Hawaii Senate Bill SCR94

Hawaii 2023 Regular Session

• Introduced: 3/10/23
• Refer: 3/15/23
• Report Pass: 4/4/23
• Engrossed: 4/5/23
• Refer: 4/11/23
• Report Pass: 4/17/23
• Passed: 4/18/23

Caption

Urging Retail Stores And Pharmacies Doing Business In The State To Adopt A Policy On A National And Local Level Guaranteeing An Individual's Unhindered Access To All United States Food And Drug Administration-approved Contraceptives.

Impact

The resolution serves as a strong call to action for local retailers and pharmacies, asking them to establish policies that will ensure complete access to contraceptives. Given that pharmacist refusals and pharmacy stock issues have been identified as barriers to access, the bill aims to reduce these obstacles. This could promote broader health equity across various demographics, particularly for vulnerable populations, including Native Hawaiians and low-income women who are at risk for unintended pregnancies.

Summary

SCR94 is a Senate Concurrent Resolution from Hawaii urging retail stores and pharmacies to adopt policies that guarantee individuals unhindered access to all FDA-approved contraceptives. The resolution highlights the significant health and social benefits of contraceptive access, particularly in reducing unintended pregnancies and supporting women's economic self-sufficiency. With a reported 47% of pregnancies in Hawaii being unintended between 2012 and 2016, the bill underscores the necessity for improved access to contraceptive options as a means of addressing health outcomes and empowering women.

Sentiment

The sentiment surrounding SCR94 appears to be supportive among health advocates and lawmakers who recognize the importance of contraceptive access for public health. The emphasis on equitable access to essential healthcare resonates with many stakeholders, although there may be some concerns from groups that oppose certain forms of contraception for moral or ideological reasons. The resolution reflects an overarching trend towards enhancing women's health and rights in healthcare decisions.

Contention

Notably, challenges may arise from retail pharmacies that may resist policy changes due to financial considerations or differing views on contraception as part of healthcare. Additionally, potential logistical issues in implementing the proposed policies at a national and local level could lead to debate about the practicalities of ensuring all pharmacies comply. The potential pushback underscores a larger discourse about reproductive rights and the accessibility of healthcare in America.